Lutze, R.D.; Ingersoll, M.A.; Kelmann, R.G.; Teitz, T.
Trametinib, a MEK1/2 Inhibitor, Protects Mice from Cisplatin- and Noise-Induced Hearing Loss. Pharmaceuticals 2024, 17, 735.
https://doi.org/10.3390/ph17060735
AMA Style
Lutze RD, Ingersoll MA, Kelmann RG, Teitz T.
Trametinib, a MEK1/2 Inhibitor, Protects Mice from Cisplatin- and Noise-Induced Hearing Loss. Pharmaceuticals. 2024; 17(6):735.
https://doi.org/10.3390/ph17060735
Chicago/Turabian Style
Lutze, Richard D., Matthew A. Ingersoll, Regina G. Kelmann, and Tal Teitz.
2024. "Trametinib, a MEK1/2 Inhibitor, Protects Mice from Cisplatin- and Noise-Induced Hearing Loss" Pharmaceuticals 17, no. 6: 735.
https://doi.org/10.3390/ph17060735
APA Style
Lutze, R. D., Ingersoll, M. A., Kelmann, R. G., & Teitz, T.
(2024). Trametinib, a MEK1/2 Inhibitor, Protects Mice from Cisplatin- and Noise-Induced Hearing Loss. Pharmaceuticals, 17(6), 735.
https://doi.org/10.3390/ph17060735